Efficacy of Oral Omega-3 Fatty Acids on Uremic Pruritis in Hemodialysis Patients

Document Type : Original Article

Authors

1 Department of dermatology, faculty of medicine, Zagazig university, Egypt

2 Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University

3 Department of of Dermatology, Venereology and Andrology, Faculty of Medicine - Zagazig University.

Abstract

Chronic kidney disease-associated pruritus (CKD-AP) is a distressing, often overlooked condition in patients with CKD and end-stage renal disease. It remains one of the most tormenting, frequent, and potentially disabling problems in patients with an advanced or end-stage renal disease who are on dialysis including peritoneal dialysis and hemodialysis. Omega-3 fatty acids are increasingly being used for their clinical benefits some of which are relevant to individuals with advanced CKD. It was found to be a safe drug that has other benefits on uremic pruritis such as reducing cholesterol, triglycerides, LDL, blood pressure, atherosclerosis, and oxidative stress.

Patient ad methods: This study was performed as a randomized, clinical trial study on 36 patients under hemodialysis three times a week, for 4 hours each session to assess the effects of Omega-3 fatty acids for treatment of pruritis in hemodialysis patients.

Conclusion: Omega-3 fatty acids was found to be a safe drug and achieved a high therapeutic response with a reasonable cost that is maintained for a relatively long period. In addition to reducing cholesterol, triglycerides, blood pressure, atherosclerosis, and oxidative stress

Keywords

Main Subjects

Zagazig University Medical Journal

Articles in Press, Accepted Manuscript
Available Online from 06 September 2021

Files

Share

How to cite

Statistics